Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Alessi

Showing results (131-140 of 147) with videos related to

Pageof 15
Sort By:
International Journal of Obesity (2005)|July 7, 2011
Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: relationship to metabolic profile, cardiac function and visceral fatB Gaborit, F Kober, A Jacquier, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 1997
Five frequent polymorphisms of the PAI-1 gene: lack of association between genotypes, PAI activity, and triglyceride levels in a healthy populationM Henry, N Chomiki, P Y Scarabin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 28, 2007
Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH studyP E Morange, N Saut, M C Alessi, et al.
Journal of Thrombosis and Haemostasis : JTH|March 25, 2014
Systemic inhibition and liver-specific over-expression of PAI-1 failed to improve survival in all-inclusive populations or homogenous cohorts of CLP miceP Raeven, S Drechsler, K M Weixelbaumer, et al.
Journal of Thrombosis and Haemostasis : JTH|January 6, 2007
Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene studyP E Morange, S Blankenberg, M C Alessi, et al.
Scientific Reports|April 5, 2017
Protein S Heerlen mutation heterozygosity is associated with venous thrombosis riskP Suchon, M Germain, A Delluc, et al.
Diabetologia|April 12, 2007
C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat dietM Poggi, D Bastelica, P Gual, et al.
Journal of Thrombosis and Haemostasis : JTH|January 26, 2010
Prothrombin G20210A carriers the genetic mutation and a history of venous thrombosis contributes to thrombin generation independently of factor II plasma levelsG Lavigne-Lissalde, C Sanchez, C Castelli, et al.
International Journal of Obesity (2005)|March 17, 2015
CD28 deletion improves obesity-induced liver steatosis but increases adiposity in miceM Poggi, S O Morin, D Bastelica, et al.
Diabetologia|February 3, 2009
The inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytesM Poggi, J Jager, O Paulmyer-Lacroix, et al.
Pageof 15

Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
International Journal of Obesity (2005)|July 7, 2011
Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: relationship to metabolic profile, cardiac function and visceral fatB Gaborit, F Kober, A Jacquier, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 1997
Five frequent polymorphisms of the PAI-1 gene: lack of association between genotypes, PAI activity, and triglyceride levels in a healthy populationM Henry, N Chomiki, P Y Scarabin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 28, 2007
Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH studyP E Morange, N Saut, M C Alessi, et al.
Journal of Thrombosis and Haemostasis : JTH|March 25, 2014
Systemic inhibition and liver-specific over-expression of PAI-1 failed to improve survival in all-inclusive populations or homogenous cohorts of CLP miceP Raeven, S Drechsler, K M Weixelbaumer, et al.
Journal of Thrombosis and Haemostasis : JTH|January 6, 2007
Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene studyP E Morange, S Blankenberg, M C Alessi, et al.
Scientific Reports|April 5, 2017
Protein S Heerlen mutation heterozygosity is associated with venous thrombosis riskP Suchon, M Germain, A Delluc, et al.
Diabetologia|April 12, 2007
C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat dietM Poggi, D Bastelica, P Gual, et al.
Journal of Thrombosis and Haemostasis : JTH|January 26, 2010
Prothrombin G20210A carriers the genetic mutation and a history of venous thrombosis contributes to thrombin generation independently of factor II plasma levelsG Lavigne-Lissalde, C Sanchez, C Castelli, et al.
International Journal of Obesity (2005)|March 17, 2015
CD28 deletion improves obesity-induced liver steatosis but increases adiposity in miceM Poggi, S O Morin, D Bastelica, et al.
Diabetologia|February 3, 2009
The inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytesM Poggi, J Jager, O Paulmyer-Lacroix, et al.
Pageof 15